MM still under GCQ, baka abutin na tayo ng 2022 ng GCQ
so lumalabas wala pa talaga history viral vector?
Guinea pig bagsak ng mga tao. PEro ok lagn kasi sosy made in united kngdom. Naturukan ang monarchy, king, queen, prince, princess. Fairtytale si tsikoteers so posh nakikibelong.
Haaaay buhay talaga peeenoise. Hindi tumintingin ng ingredients kaya nga-nga.
Parang hanes lang. Made in USA pero bacon neck after one wash. Bili pa din mga gagah hahahahahah
meron naman history pero relatively recent lang din ang adenoviral vector vaccines
mas nauna lang ng konte sa mRNA vaccines
Magalong resigns as contact tracing czar, but rejected by Covid-19 task force | Inquirer News
Naturally ayaw nila. Mapapahiya sila eh.
Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says - CNN
Johnson & Johnson's Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial, but 85% efficacy against severe disease, the company announced Friday.
The vaccine was 72% effective against moderate and severe disease in the US, the company said.
It's a striking difference from vaccines from Pfizer/BioNTech and Moderna, and it may give pause to people uncertain about which vaccine to get or when they can get one. The vaccines already on the market in the US are about 95% effective overall against symptomatic Covid-19, with perhaps even higher efficacy against severe cases.
But experts say the Johnson & Johnson vaccine will still be useful against the pandemic in the United States and around the world.
"Among all participants from different geographies and including those infected with an emerging viral variant, Janssen's COVID-19 vaccine candidate was 66% effective overall at preventing the combined
endpoints of moderate and severe COVID-19, 28 days after vaccination. The onset of protection was observed as early as day 14," the company said in a statement.
"The level of protection against moderate and severe COVID-19 infection was 72% in the US, 66% in Latin America and 57% in South Africa, 28 days post-vaccination."
"We're 85% effective at preventing severe disease, which we define as disease that makes you feel particularly sick at home, or may go to the hospital, or worse," Dr. Mathai Mammen, global head of research and development at Johnson & Johnson, told CNN.
"And we are right now completely protective, it would appear 100% protective, against disease that actually does make you go to the hospital, we're 100% protective against death."
Last edited by Monseratto; January 29th, 2021 at 10:40 PM.
Covid-19 vaccines... ako kahit anong brand basta yung pinaka less ang side effect... parang commin flu vac lang sana na side effect...
swelling, redness, or discoloration at the injection site.
low grade fever.
headache.
muscle aches and pains.
fatigue.
nausea.
Ayaw ko yung may possible allergies...
60% protection is still better than nothing... plus vits and healthy lifestyle and follow the health protocol... sure na ako to survive 2021 huwag lang ma hold-up at mabaril or masagasaan... [emoji1787][emoji1787][emoji1787]
Sent from my iPhone using Tapatalk
Happy 1st Anniversay CHINA WUHAN VIRUS in the Philippines: Philippines marks 1st year since confirming first COVID-19 case
A direct import from Wuhan, tsina
Kung sinabi lang ng mas maaga sana hindi na nakapasok itong lintek na turista
![]()
![]()
Last edited by 111prez; January 30th, 2021 at 08:30 AM.
The favorite among private companies has a lower than J&J vaccine efficacy...60%
EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU | European Medicines Agency
The safety of the vaccine has been demonstrated across the four studies. However, the Agency based its calculation of how well the vaccine worked on the results from study COV002 (conducted in the UK) and study COV003 (conducted in Brazil). The other two studies had fewer than 6 COVID-19 cases in each, which was not enough to measure the preventive effect of the vaccine. In addition, as the vaccine is to be given as two standard doses, and the second dose should be given between 4 and 12 weeks after the first, the Agency concentrated on results involving people who received this standard regimen.
These showed a 59.5% reduction in the number of symptomatic COVID-19 cases in people given the vaccine (64 of 5,258 got COVID-19 with symptoms) compared with people given control injections (154 of 5,210 got COVID-19 with symptoms). This means that the vaccine demonstrated around a 60% efficacy in the clinical trials.
Most of the participants in these studies were between 18 and 55 years old. There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group. However, protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines; as there is reliable information on safety in this population, EMA’s scientific experts considered that the vaccine can be used in older adults. More information is expected from ongoing studies, which include a higher proportion of elderly participants.
COVID-19 Vaccine AstraZeneca is given as two injections into the arm, the second between 4 to 12 weeks after the first. The most common side effects with COVID-19 Vaccine AstraZeneca were usually mild or moderate and got better within a few days after vaccination. The most common side effects are pain and tenderness at the injection site, headache, tiredness, muscle pain, general feeling of being unwell, chills, fever, joint pain and nausea. The safety and effectiveness of the vaccine will continue to be monitored as it is used across the EU, through the EU pharmacovigilance system and additional studies by the company and by European authorities.
Last edited by Monseratto; January 30th, 2021 at 10:48 AM.